PharmaSwiss

​  Latest News

Access denied. You do not have permission to perform this action or access this resource.

Our Company Profile

 

In February 2011, Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A., announced their agreement for Valeant to acquire PharmaSwiss, a privately-owned branded generics and over-the-counter (OTC) pharmaceutical company based in Zug, Switzerland. The acquisition was complete in March 2011. PharmaSwiss has a broad product portfolio in seven therapeutic areas and operations in nineteen countries throughout Central and Eastern Europe, including Poland, Hungary, the Czech Republic and Serbia. The company also has operations in Greece and Israel. PharmaSwiss had annual revenues of approximately euro 180 million in 2010 and has been growing at approximately 20% per year over the past 5 years.
 
PharmaSwiss employs approximately 760 employees spread across its 19 countries, operating an EU GMP capsuling and packaging facility which is being significantly expanded and backwards-integrated. In addition, PharmaSwiss is an existing partner to several large pharmaceutical and biotech companies offering regional expertise in such functions as regulatory, compliance, sales, marketing and distribution.

 

More about our company 

Our Territories

 

Interactive map

​Press Releases & Company Announcements

Access denied. You do not have permission to perform this action or access this resource.